Caplin Point Laboratories Ltd
NSE: CAPLIPOINT BSE: 524742
₹2297.10
-41.10 (1.76%)
Fri, 23 Oct 2026, 06:13 pm
Market Cap (in Cr)17940.66
PE Ratio26.32
Dividend0.34
Health Technology
Pharmaceuticals: Major
24.5KCaplin Point Laboratories Financials
| Particulars | Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 377.71M | 495.14M | 591.19M | 580.53M | 779.21M | 1.04B | 1.23B | 1.69B | 3.08B | 3.90B | 5.26B | 6.33B | 8.45B | 10.48B | 12.63B | 14.54B | 16.77B | 19.21B |
| Gross profit | 38.28M | 2.10M | 12.84M | 39.42M | 89.92M | 166.01M | 250.94M | 416.98M | 903.64M | 1.37B | 2.05B | 2.45B | 3.02B | 4.06B | 5.02B | 5.58B | 6.82B | 8.29B |
| Operating expenses (excl. COGS) | -21.16M | -2.10M | -1.60M | -36.03M | -51.48M | -52.57M | -60.99M | -100.92M | -204.75M | -361.70M | -426.92M | -517.64M | -911.77M | -1.22B | -1.55B | -1.69B | -1.94B | -2.54B |
| Selling/general/admin expenses, total | — | — | — | -35.23M | -50.65M | -48.60M | -58.47M | -97.44M | -199.49M | -339.47M | -394.11M | -517.64M | -911.77M | -1.12B | -1.55B | -1.69B | -1.94B | -2.43B |
| Research & development | — | — | — | — | — | -5.85M | -3.67M | -20.80M | -72.46M | -140.88M | -236.81M | -281.86M | -530.14M | -536.95M | -592.70M | -631.90M | -737.20M | -766.80M |
| Selling/general/admin expenses, other | — | — | — | -35.23M | -50.65M | -42.75M | -54.80M | -76.64M | -127.03M | -198.59M | -157.30M | -235.78M | -381.63M | -582.68M | -961.10M | -1.06B | -1.21B | -1.67B |
| Other operating expenses, total | -21.16M | -2.10M | -1.60M | -801.57K | -829.49K | -3.97M | -2.52M | -3.47M | -5.26M | -22.23M | -32.81M | 0 | 0 | -105.00M | 0 | 0 | 0 | -109.90M |
| Operating income | 17.11M | -591.2 | 11.24M | 3.39M | 38.44M | 113.44M | 189.96M | 316.06M | 698.89M | 1.01B | 1.62B | 1.93B | 2.11B | 2.84B | 3.46B | 3.89B | 4.87B | 5.75B |
| Non-operating income, total | 5.65M | 9.72M | 20.45M | 33.10M | 43.80M | -1.72M | 31.45M | 40.85M | 101.36M | 202.92M | 262.46M | 341.24M | 586.90M | 297.99M | 393.80M | 624.40M | 768.20M | 1.02B |
| Interest expense, net of interest capitalized | -6.29M | -6.68M | -9.55M | -8.34M | -10.02M | -8.22M | -1.72M | -6.82M | -4.49M | -5.17M | -6.10M | -5.81M | -11.84M | -15.90M | -7.00M | -7.80M | -7.80M | -6.10M |
| Interest capitalized | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 12.03M | 17.72M | 30.04M | 41.43M | 53.83M | 6.50M | 33.17M | 47.67M | 105.85M | 207.04M | 251.24M | 312.79M | 593.87M | 357.78M | 402.20M | 637.60M | 767.30M | 1.01B |
| Non-operating interest income | 2.46M | 4.35M | 13.14M | 12.11M | 12.65M | 23.81M | 20.43M | 24.00M | 46.96M | 59.26M | 30.37M | 19.92M | 74.58M | 186.07M | 235.00M | 354.10M | 472.80M | 636.40M |
| Miscellaneous non-operating expense | 9.58M | 13.37M | 16.90M | 29.32M | 41.18M | -17.31M | 12.74M | 23.66M | 58.89M | 147.78M | 220.22M | 289.68M | 511.72M | 161.08M | 151.80M | 267.60M | 274.40M | 355.30M |
| Unusual income/expense | -95.85K | -1.32M | -32.20K | — | — | — | — | — | — | 1.05M | 17.32M | 34.27M | 4.88M | -43.89M | -1.40M | -5.40M | 8.70M | 11.10M |
| Pretax income | 22.76M | 9.71M | 31.70M | 36.48M | 82.25M | 111.72M | 221.40M | 356.91M | 800.25M | 1.21B | 1.88B | 2.27B | 2.69B | 3.14B | 3.86B | 4.51B | 5.64B | 6.77B |
| Taxes | -8.32M | -1.70M | -9.44M | -3.17M | -19.13M | -31.43M | -81.19M | -97.58M | -190.44M | -254.44M | -437.43M | -503.21M | -543.79M | -621.88M | -773.70M | -743.60M | -1.03B | -1.36B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | -290.99K | -234.00K | -376.00K | -842.00K | -57.33K | 1.09M | 1.53M | 116.00K | -757.00K | -91.64M | -86.10M | -7.30M | -43.30M | -47.80M |
| After tax other income/expense | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 14.44M | 8.02M | 22.26M | 33.32M | 62.82M | 80.06M | 139.84M | 258.49M | 609.75M | 956.12M | 1.45B | 1.77B | 2.15B | 2.42B | 3.00B | 3.76B | 4.57B | 5.36B |
| Net income | 14.44M | 8.02M | 22.26M | 33.32M | 62.82M | 80.06M | 139.84M | 258.49M | 609.75M | 956.12M | 1.45B | 1.77B | 2.15B | 2.42B | 3.00B | 3.76B | 4.57B | 5.36B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Diluted net income available to common stockholders | 14.44M | 8.02M | 22.26M | 33.32M | 62.82M | 80.06M | 139.84M | 258.49M | 609.75M | 956.12M | 1.45B | 1.77B | 2.15B | 2.42B | 3.00B | 3.76B | 4.57B | 5.36B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 31.40M | 20.06M | 31.34M | 24.31M | 61.68M | 125.81M | 205.36M | 351.43M | 798.59M | 1.14B | 1.81B | 2.16B | 2.42B | 3.21B | 3.93B | 4.34B | 5.41B | 6.41B |
| EBIT | 17.11M | -590 | 11.24M | 3.39M | 38.44M | 113.44M | 189.96M | 316.06M | 698.89M | 1.01B | 1.62B | 1.93B | 2.11B | 2.84B | 3.46B | 3.89B | 4.87B | 5.75B |
| Total operating expenses | -360.59M | -495.14M | -579.95M | -577.15M | -740.77M | -926.85M | -1.04B | -1.37B | -2.39B | -2.90B | -3.63B | -4.40B | -6.34B | -7.64B | -9.17B | -10.65B | -11.89B | -13.46B |
| Prepaid expenses | — | — | — | — | 33.36M | — | — | — | — | 14.96M | — | — | — | — | — | — | 18.00M | 136.00M |
| Deferred income, current | — | — | — | — | — | — | — | 592.82M | — | 187.37M | 3.84M | 0 | — | — | 54.90M | 225.30M | 308.10M | 118.60M |
| Capital and operating lease obligations | 1.83M | 1.09M | 4.73M | 3.91M | 2.82M | 0 | 34.84M | 20.72M | 0 | 3.22M | 3.22M | 2.87M | 12.85M | 5.33M | 11.70M | 9.30M | 9.20M | 29.10M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 4.66M | 11.91M | 10.84M | 10.87M | 16.33M | 26.13M | 48.30M | 75.74M | 113.35M | 189.66M | 221.61M | 225.42M | 221.39M | 209.71M | 217.90M | 141.40M | 90.70M | 30.10M |
| Deferred income, non-current | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | 28.70M | 0 |
| Minority interest | 0 | 0 | 0 | 0 | 295.99K | 535.00K | 928.00K | 1.77M | 2.71M | 3.62M | 904.00K | 788.00K | 86.57M | 175.38M | 259.50M | 267.90M | 311.20M | 359.00M |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -136.40M | -63.65M | -113.36M | -151.21M | -325.26M | -30.26M | -226.90M | -303.20M | -341.70M | -379.90M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
